The primary aim of the study is to evaluate and improve atrial fibrillation risk predcition, which takes into account clinical, psycho-social, environmental and lifestyle-risk factors, protein patterns and genetic variability in addition to the classical risk factors with respect to the primary endpoint, AF (paroxysmal or permanent).
AFHRI is planned as a prospective, single-center cohort study in patients at high risk of AF.